Σωτήρης Κ. Αδαμίδης

Βιογραφικό Σωτήρη Κ. Αδαμίδη

PERSONAL INFORMATION

  • Director Department of Internal Medicine, Athens Medical Center

  • 5-7 Distomou Street 15125 Maroussi Athens Greece

  • +30210 6157107 fax : +30 210 6120977

  • Private office : 40 Thisseos Street Maroussi Athens Greece, 15124

  • +30210 8069971 fax : +30210 6109028


  • mobile : + 30 6934 30 49 93

  • e-mail : adamidis@yahoo.com

EDUCATION

1971-1978

Medicine Athens Medical School, Athens University

1978-1980

Greek Army, Health Department

1980-1983

Director : Akrata’s Health Center, Patra, Greece

1984-1986

Residency : IM ,CD, PUD, University of Athens, Athens ,Greece

1984-1988

Ph.D. Athens University, School of Medicine, Department of Pathologic Physiology «Dissertation title : β-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients and those on crisis.» Dissertation director : Professor Anthi Travlou

PROFESSIONAL EXPERIENCE

Years Description
1977-1978
Graduate Teaching Assistant, Department of Path ophysiology
1984-1986
Teaching Assistant, 1st Department of Internal Medicine, Athens University, Athens
1984-1986
Research Assistant Department of Pathophysiology Athens University, Athens
1986-present
Private Practice, Internal Medicine, Athens
1990-present
Director, Athens Medical Center Hospital, Internal Medicine Department, Athens
HONORS AND AWARDS
Fellow International Academy of Chest Physician and Surgeon’s - American College of Chest Physicians.
American Heart Association - Council member.
Scientific Council : Clinical Cardiology. (AHA)
American Diabetes Association.
American Hypertension Society.
Vista Link International Medical Consultants Network member. (internet based continuing medical education program development)
Editorial Advisory Board - Vita - 1999-2001.
Editorial Advisory Board - Medical World - 1996-present.
Hellenic Society of Internal Medicine.
Hellenic Thoracic Society.
Hellenic anti Cancer Society.
American College of Chest Physicians.
Chron’s and Colitis Foundation of America.
European Association for the Study of Obesity.
American Association of Clinical Endocrinologists.
Chairman of scientific protocol approval committee - Athens Medical Center.
Chairman of the scientific Society of Athens Medical Center.
Chairman of scientific committee on medicinal products - Athens Medical Center.
The American Biographical Institute (since:2005).
Hellenic Medical Assosiation for Obesity.
Heart Failure Association – The European Society of Cardiology.
American Stroke Association / Vascular Biology Member.
Behavioral Medicine and Biology – ASC.

PUBLISHED ARTICLES

  • Application of full therapy with the administration of primaquine in malaria from P. falciparum in countries where the anopheles is endemic but not the disease. Nicosia, Cyprus. / G. Panos , A. Greka, A. Nastos , G. Tsikkinis, M A Astriti, E. Giannatou, S. Adamidis. 1st Cyprus Congress of Chemotherapy and Infectious Diseases, 31/3 – 2/4/2000.

  • Statistical model depicting the rate of change of CD4 cells and viral load from initiation of antiretroviral therapy in experienced HIV (+) Patients. I. Karidis, I. Giannakopoulou, A. Trikalinou, E. Giannatou, S. Adamidis, V. Vasdekis, G. Panos. 13th Panhellenic AIDS Congress, page 52, Athens Oct/Nov 2001

  • Total recording of primary and secondary mutations in HIV seropositive patients ; a comparison with the international bibliographic data E. Giannatou, I. Karidis, A. Trikalinou, S. Adamidis, G. Panos. Hellenic Archives of AIDS, Vol .9, Issue 2, page 89-92, 2001.

  • Record of primary and secondary mutations of ZDV and LMV in HIV seropositive patients ; comparison with the international bibliographic data. E. Giannatou, Trikalinou A, I. Karidis, S. Adamidis, G. Panos.

  • Genotypic profile of primary and secondary mutations in Greek HIV (+) patients with virologic success while they receive a new HAART combination E. Giannatou, Trikalinou A, I. Karidis, S. Adamidis, G. Panos HIV Unit, 1st IKA Hospital, Athens, Greece. 13th, Panhellenic AIDS Congress, p.54 Athens Oct/Nov 2001.

  • Fluctuation of viral load under new salvage antiretroviral treatment in multiresistant-multiexperienced to protease inhibitors HIV (+) patients . I.Karides, A. Trikalinou, A.Filandras, S .Melenikli, S. Adamidis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 65, Athens Oct/Nov 2001.

  • Fluctuation of CD4 under new salvage antiretroviral treatment in multiresistant-multiexperienced to protease inhibitors HIV (+) patients . I.Karides, A. Trikalinou, A.Filandras, S .Melenikli, S. Adamidis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 66, Athens Oct/Nov 2001.

  • Co- existence of cutaneous and visceral Leismaniasis in a HIV seropositive patient. A. Trikalinou, I.Karides, Giannatou E, A.Filandras, S. Adamidis ,G.Kontelis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 67, Athens Oct/Nov 2001.

  • Double protease ( PI ) and NNR1( Iopinavir/Vitozevir/Saquinavir-HG/Delaverdine) as a successful salvage therapy in HIV (+) patients with lactic acidosis and multiple genotypic resistance in NNRTIs and PIs A. Roussou , F. Syrrokosta, I. Karides, S. Melenikli, S. Adamidis, G. Panos HIV Unit ,1st IKA Hospital,Penteli ,Athens . Common 18th Pancyprian Medical Congress and 2nd Pancyprian Congress of Chemotherapy and Infectious Diseases, 12-15 Sept 2002, Nicosia Cyprus, p. 28, No 10.

  • Cystic adenomatoid hyperplasia of an embryo in a HIV (+) pregnant woman receiving HAART from the 10th week of pregnancy and for 4 weeks when the diagnosis was made . A. Roussou , F. Syrokosta,I. Karides,S.Melenikli, S.Adamidis,D. Haritatos,D.Papanikolaou,G.Panos Common 18th Pancyprian Medical Congress and 2nd Cyprus Congress of Chemotherapy and Infectious Diseases, 12-15 Sept 2002, Nicosia Cyprus, p. 33, No 17.

  • Staphylococcus hominis infection in a HIV(+) patient receiving HAART with pyoderma and respiratory infectia

  • “Inhale drug consumption and asthma mortality in Greece”, CHEST –Volume 107, June 6 ,1995

  • “A case of diabetes following tibolone therapy”, MATURITAS – December 1993

  • “Evaluation of metaholine bronchial provocation test in asthmatics” Kioto,-Japan, October 1991

  • “A study of β-thromboglobulin and platelet factor -4 plasma levels in steady state sickle cell patients.” Blut , July 11, 1990

  • “Nocturnal Asthma and biological (circadian) rhythms”, Greek Medical Chronicles , Volume 1984

  • High incidence of celiac disease in Greek patients with digestive symptoms” 9th Pan-Hellenic congress of internal medicine, October 6-11,2003 Athens

  • “Automatic pneumomediastinum in adults 20 years” ” 12th Pan-Hellenic congress of Pulmonary Diseases, December 3-7,2003 Athens

BOOKS PUBLISHED

  • Patristic Therapeutics and Psychoanalysis Stamoulis publications,university press , 2002Athens Greece

  • Obesity ,Metabolic Syndrome and Diabetes, 2010 Stamoulis Publ. 2010, Athens Greece

PRESENTATIONS AS A SPEKEAR IN NATIONAL AND INTERNATIONAL CONGRESS

  • Hellenic Lipid Management Series ,Amirandes , Herakleion , Greece Managing Cholesterol Levels: Awareness, Treatment , and Control Of Hypercholesterolaemia May 2005

  • «Recent developments in prevention and treatment of cardiovascular risk/ hypertension and hyperlipidemia» June 26,2006 Greece

  • Sildenafil plus Atorvastatin in patients with Metabolic Syndrome and Erectile Dysfunction: Effectiveness and safety Issues. Vascular Biology Working Group meeting. October 19 , 2006 , Milan Italy

  • The role of TZDs in the prevention and treatment of T2D 10 years history of TZDs, Important Data for Clinical Practice. Nov 19 ,2010 , Krakovia Polland International Endocrinogy Congress

  • Pathophysiology of T2D .Insulin Resistance and Beta Cell Function .The role of sitagliptin in the therapeutic Algorythm Aldemar ,Olympia , Greece .Sept 30,2011.

NATIONAL AND INTERNATIONAL CONGRESSES
“A new oral therapy for pulmonary arterial hypertension via phosphodiesterase-5 (PDE 5 ) inhibition” 12th October
“ESC Congress 2004” September 2004 - Munich – Germany
“XVIIth Congress of the European Society of Cardiology”Amsterdam Netherlands 19-24 August 1995
XXIIth Congress of the European Society of Cardiology” Netherlands 26-30 August 2000
“66th Scientific Session – American Diabetes Association Annual Meeting” 9-13 June 2003 – Washington
“Towards a better outcome in the management of UCAD” Open live telesymposium - Thursday 12 December 1996
International Diabetes Federation – Le Palais de Congress - Paris 24-29 August 2003
“1st Balkan Congress on Obesity – 5th Pan-Hellenic Medical Congress on Obesity” February 6-9 - 2003 Athens Greece
“6th International Symposium on “Global Risk of Coronary Heart Disease and Stroke: Assessment - Prevention and Treatment” Florence - June 12-15 - 2002
International Association of Obesity - International Diabetes Federation “ Orchestrating Success” Berlin - March 25-28 - 2004
“International Symposium “ Calcium antagonism plus beta- blockade – opposites or synergism?”
“XXth Congress of the European Society of Cardiology” 22-26 August 1998 – Vienna
“State of Heart Protection: New Clinical Developments in the treatment of Coronary Heart Disease” Seville - Spain - February 22-23 - 2002
“Scientific Symposium cox –II inhibition- A clinical Update on Safety and Efficacy” London - April 2001
“XXIst Congress of the European Society of Cardiology” 22-26 August 1999 – Barcelona- Spain
“11th Scientific Meeting of the American Society of Hypertension” May 15-18 - 2006 –New York - USA
“Interaktion oder Synergismus zwischen Beta-Rezeptorenblockern und NOCTAMID” August 1984 - Deutschland
“The second international postgraduate medical symposium - Advances in Cardio-Pulmonary medicine” Salzburg - February 2nd - 1989
“64th Scientific Session - June 4-8 - 2004” Orlando - Florida
“The 13th European Congress on Obesity” Prague – Czech Republic - May 26-29 - 2004
“74th European Atherosclerosis Congress” - April 17-20 - 2004
“World Congress on Controversies in Obesity - Diabetes and Hypertension (CODHy). October 26-29 - 2007.
RC33 6th International Conference on Social Science Methodology 2004.
“Targeting Cardiovascular Disease in Type 2 Diabetes: Making the Link” 22-24 April - 2004 –Athens - Greece
“18th Conference of the International Diabetes Federation” Paris - 24-29 August 2003
“XV International Congress of Allergology and Clinical Immunology” Annual Meeting - June 26- July 1 - 1994 Stockholm – Sweden
“XIV International Congress of Allergology and Clinical Immunology” Annual Meeting - October 13-18 - 1991
“Epidemiology Safety Evaluation of Losec Therapy in patients of Northern Attica” - June 22 - 1999 – Northern Attica
“The Second International Postgraduate Medical Symposium –Advances in Cardio-Pulmonary” January 30th – February 2nd - 1989 - Salzburg – Austria
“74th EAS Congress” March 18th - 2004 - Seville- Spain
“Sildenafil plus atrovastatin in patients suffering from E.O. and metabolic syndrome” European Chapter Meeting - October 20-21 - Milan - Italy
“The acute effect of wood coal production on pulmonary function” ESR Annual Congress - September 25th – 29th - 1993 - Firenze - Italy
“Hypertension and Cardiovascular Risk” - Thessaloniki - March 14-16 - 2002
“New data in the treatment of chronic diseases of the digestive system and application in daily clinical practice” March 10-11 - 2007 – Greece
“High incidence of celiac disease in Greek patients with digestive symptoms” 9th Pan-Hellenic congress of internal medicine - October 6-11 - 2003 Athens
Automatic pneumomediastinum in adults 20 years” ” 12th Pan-Hellenic congress of Pulmonary Diseases - December 3-7 - 2003 Athens
“A study of β-thromboglobulin and platelet factor -4 plasma levels in steady state sickle cell patients.” 2nd Pan-Hellenic Hematology Congress - November 1-3 - 1985- Athens
“Fibrous dysplasia of temporal bone” 10th Pan-Hellenic Otolaryngology Congress - October 6-10 - 1999 – Greece

RESEARCH ACTIVITY – SCIENTIFIC PROTOCOLS

  • “ Flu Surveillance Program” Tamiflu, Roche Global Team , 1999-2000
  • Training Program Director in Clinic of Internal Medicine in Athens Medical Center
  • Training Program Director in Clinic of Internal Medicine in Semmelweis University , Budapest
  • “Treatment of peptic ulcer with famotidine” (a multicenter study in Greece), Adamidis S. et all
  • “Multicenter study evaluating the clinical efficacy and safety of cefprozil in the treatment of infections of lower respiratory tract” , Adamidis S. et all
  • “Changes in systolic blood pressure index after antihypertensive treatment with quinapril”
  • «Clinical assessment of lipid profiles in patients with type 2 diabetes receiving combined oral treatment»
  • “Program of clinical practice in pharmacy school graduates – MCs in Clinical Practice”2001-2002/2004-2005